Literature DB >> 4896070

Modification of established rejection of canine kidney and liver homografts with antilymphocyte gamma-G globulin.

G V Smith, J Kolff, N Kashiwagi, C W Putnam, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4896070      PMCID： PMC2975398     

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  8 in total

1.  The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

Authors:  T E Starzl; T L Marchioro; K A Porter; Y Iwasaki; G J Cerilli
Journal:  Surg Gynecol Obstet       Date:  1967-02

2.  Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production.

Authors:  N Kashiwagi; C G Groth; J R Amend; L Gecelter; H Blanchard; T E Starzl
Journal:  Surgery       Date:  1969-03       Impact factor: 3.982

3.  Prolongation of canine renal allograft survival with antilymphocytic serum.

Authors:  G J Clunie; B Nolan; K James; J G Watt; M F Woodruff
Journal:  Transplantation       Date:  1968-05       Impact factor: 4.939

4.  Impairment of delayed hypersensitivity in uremic patients by antilymphocyte serum.

Authors:  F H Brunstetter
Journal:  Transplantation       Date:  1968-05       Impact factor: 4.939

5.  Heterologous antilymphocyte serum: differential effect on antigen-sensitive and antibody-producing cells.

Authors:  G Möller; C F Zukoski
Journal:  Surgery       Date:  1968-07       Impact factor: 3.982

6.  Nature and mode of action of antilymphocytic antiserum.

Authors:  R H Levey; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1966-10       Impact factor: 11.205

7.  Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response.

Authors:  A P Monaco; M L Wood; J G Gray; P S Russell
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

8.  The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors:  B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307
  8 in total
  1 in total

1.  Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.

Authors:  J J Fung; A J Demetris; K A Porter; S Iwatsuki; R D Gordon; C O Esquivel; R Jaffe; A Tzakis; B W Shaw; T E Starzl
Journal:  Nephron       Date:  1987       Impact factor: 2.847
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.